Struthers Richard Scott

Struthers Richard Scott is listed in filings as President & CEO at Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX). This profile follows SEC Form 4 activity through Jun 2, 2026, including sale activity. Recent filings connect the profile to Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) (CRNX). The current snapshot covers public activity from Dec 4, 2024 to Jun 2, 2026. Reported amounts are shown as $489.7K to $10.0M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.